| Description | Luspatercept (ACE-536), a recombinant modified ActRIIB fusion protein, selectively binds to transforming growth factor β superfamily ligands, thereby enhancing erythrocyte production and advancing the maturation of erythroid precursors. Moreover, by binding with GDF11, it inhibits Smad2/3 signaling. This compound is instrumental in anemia research [1]. |
| molecular weight | N/A |
| CAS | 1373715-00-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |